Cingulate Inc. Other Current Liabilities
Cingulate Inc. (CING) had Other Current Liabilities of $339.75 thousand as of 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Balance Sheet › Liabilities
us-gaap:OtherLiabilitiesCurrent · last filed 2023-03-10
- 2022-12-31: Other Liabilities, Current $339.75K.
- 2022-09-30: Other Liabilities, Current $326.74K.
- 2022-06-30: Other Liabilities, Current $314.10K.
- 2022-03-31: Other Liabilities, Current $303.26K.
| Period end | Other Liabilities, Current |
|---|---|
| 2022-12-31 | $339.75K 10-K · filed 2023-03-10 |
| 2022-09-30 | $326.74K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $314.10K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $303.26K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $295.60K 10-K · filed 2023-03-10 |
| 2020-12-31 | $234.17K 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |